- World rank, all time
- #20,021 of 42,892
- Rank in United States
- #4,331 of 8,685
- Research works
- 245 ▼ 43% vs 2013–17
- Citations
- 10k 41.6 per fractional work
- Top-10% rate
- 28.8% record average 16.5%
- Open access
- 37% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.6×
- Immunology and Microbiology 4.4×
- Nursing 3.2×
- Pharmacology, Toxicology and Pharmaceutics 3.0×
- Medicine 2.8×
- Chemistry 0.6×
- Earth and Planetary Sciences 0.5×
- Materials Science 0.4×
- Physics and Astronomy 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Engineering 0.2×
Who are the top researchers at Array BioPharma (United States)?
Ranked on the composite score, Deborah Anderson and Patrice A. Lee lead among researchers whose main affiliation is Array BioPharma (United States).
- 1 Deborah Anderson United States · #1,319,375 worldwide 21 citations · 27 works
- 2 Patrice A. Lee United States · #1,614,052 worldwide 8 citations · 19 works
Which keywords describe research at Array BioPharma (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Medicinal Chemistry, Oncogenic Mutations, Immune Response, Signal Transduction, Cell Proliferation, Melanoma and Cancer.
- HER2
- Peptide Synthesis
- Foldamers
- Biological Evaluation
- Protein-Protein Interactions
- Monoclonal Antibody
- Virtual Screening
- Drug Target Identification
- Cancer Progression
- Molecular Docking
- Signaling
- Metabolism
- Anticancer Agents
- Chemotherapy
- Synthesis
- MAP Kinase
- Melanoma
- Signal Transduction
- Immune Response
- Medicinal Chemistry
- Cancer Therapy
- Oncogenic Mutations
- Cancer
- Cell Proliferation
- BRAF gene
- Inflammation
- Drug Discovery
- Pharmacokinetics
- Transcriptional Regulation
- Breast Cancer
- Metastasis
- Heterocyclic Compounds
- Cell Division
- Microtubules
- Phosphorylation
- Pim Oncogenes
- Tumorigenesis
- Cell Migration
- Metastatic
- Receptor tyrosine kinases
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy40▲ 26×13 topics
- Medicinal Chemistry22▲ 25×11 topics
- Oncogenic Mutations22▲ 197×2 topics
- Immune Response20▲ 14×11 topics
- Cancer18▲ 5.2×22 topics
- Signal Transduction16▲ 26×3 topics
- Cell Proliferation15▲ 68×2 topics
- Melanoma15▲ 120×2 topics
- BRAF gene15▲ 342×1 topic
- MAP Kinase15▲ 342×1 topic
- Inflammation15▲ 2.5×29 topics
- Synthesis13▲ 9.4×12 topics
- Drug Discovery13▲ 14×9 topics
- Chemotherapy12▲ 7.1×11 topics
- Pharmacokinetics11▲ 17×3 topics
- Anticancer Agents11▲ 18×6 topics
- Transcriptional Regulation11▲ 18×8 topics
- Metabolism11▲ 6.8×8 topics
- Breast Cancer10▲ 15×6 topics
- Signaling9▲ 33×4 topics
- Metastasis9▲ 11×6 topics
- Molecular Docking9▲ 26×2 topics
- Heterocyclic Compounds9▲ 23×2 topics
- Cancer Progression9▲ 15×4 topics
- Cell Division8▲ 95×1 topic
- Drug Target Identification8▲ 49×1 topic
- Microtubules8▲ 95×1 topic
- Virtual Screening8▲ 49×1 topic
- Phosphorylation8▲ 122×2 topics
- Monoclonal Antibody8▲ 46×2 topics
- Pim Oncogenes8▲ 176×1 topic
- Protein-Protein Interactions8▲ 30×2 topics
- Tumorigenesis8▲ 58×1 topic
- Biological Evaluation8▲ 25×3 topics
- Cell Migration8▲ 36×3 topics
- Foldamers8▲ 38×1 topic
- Metastatic8▲ 48×2 topics
- Peptide Synthesis8▲ 38×1 topic
- Receptor tyrosine kinases8▲ 69×2 topics
- HER27▲ 99×1 topic
Which research topics does Array BioPharma (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling and Wound Healing and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 1 works
- 2 Melanoma and MAPK Pathways Molecular Biology 1 works
- 3 Protein Kinase Regulation and GTPase Signaling Molecular Biology 0 works
- 4 Wound Healing and Treatments Rehabilitation 0 works
- 5 Reconstructive Surgery and Microvascular Techniques Surgery 0 works
- 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 7 Tissue Engineering and Regenerative Medicine Surgery 0 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 10 Biopolymer Synthesis and Applications Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Array BioPharma (United States)'s research output changed?
Output in 2018–2022 was 43% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boulder
- University of Colorado Boulder
- University of Colorado System
- NSF National Center for Atmospheric Research
- Cooperative Institute for Research in Environmental Sciences
- Joint Institute for Laboratory Astrophysics
- Laboratory for Atmospheric and Space Physics
- NSF NCAR High Altitude Observatory
- Institute of Arctic and Alpine Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.